Macquarie Group LTD Dr Reddys Laboratories LTD Transaction History

Macquarie Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $25,008 - $29,297	-504 Reduced 55.69%	401 $22,000
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $43,684 - $59,051	905 New	905 $50,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $6.52 Million - $7.42 Million	-104,132 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$39.55 - $54.65 $4.17 Million - $5.76 Million	-105,367 Reduced 50.29%	104,132 $5.52 Million
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $4 Million - $5.28 Million	-115,084 Reduced 35.46%	209,499 $8.45 Million

Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $1.76 Million - $1.99 Million	-50,660 Reduced 13.5%	324,583 $12.3 Million
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $684,950 - $812,440	19,000 Added 5.33%	375,243 $14.1 Million
Q1 2019 May 15, 2019	BUY	$35.77 - $40.57 $89,425 - $101,425	2,500 Added 0.71%	356,243 $14.4 Million
Q4 2018 Feb 15, 2019	BUY	$31.89 - $38.44 $4.58 Million - $5.53 Million	143,743 Added 68.45%	353,743 $13.3 Million
Q3 2018 Nov 15, 2018	BUY	$29.25 - $36.73 $6.14 Million - $7.71 Million	210,000 New	210,000 $7.27 Million

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.